14159 capital (GP), LLC Insider Trading $BCRX BIOCRYST PHARMACEUTICALS INC
Get free email notifications about insider trading for 14159 capital (GP), LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of 14159 capital (GP), LLC. 14159 capital (GP), LLC is 10% Owner in HERON THERAPEUTICS, INC. /DE/ ($HRTX) and 10% Owner in BIOCRYST PHARMACEUTICALS INC ($BCRX) and Director in INCYTE CORP ($INCY) and 10% Owner in IDERA PHARMACEUTICALS, INC. ($IDRA) and 10% Owner in TAPESTRY PHARMACEUTICALS, INC ($NPRO) and 10% Owner in VIROPHARMA INC ($VPHM) and Director in SYNAGEVA BIOPHARMA CORP ($GEVA) and 10% Owner in ADOLOR CORP ($ADLR) and 10% Owner in ALLOS THERAPEUTICS INC ($ALTH) and 10% Owner in Ardea Biosciences, Inc./DE ($IBPI) and Director in Ardea Biosciences, Inc./DE ($IBPI) and Director in SEATTLE GENETICS INC /WA ($SGEN) and Director in GENOMIC HEALTH INC ($GHDX) and 10% Owner in AUXILIUM PHARMACEUTICALS INC ($AUXL).
14159 capital (GP), LLC in BIOCRYST PHARMACEUTICALS INC
Trading Symbol: BCRXIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of 14159 capital (GP), LLC: 10% Owner
Holdings: 120,828 shares
Current Value: $685,095
Latest Transaction: Jun 01 2009
$BCRX Market Capitalization: $427.06M
$BCRX Previous Close: $5.67
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of 14159 capital (GP), LLC in BIOCRYST PHARMACEUTICALS INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADLR, ALTH, IBPI, AUXL, BCRX, GHDX, HRTX, IDRA, INCY, SGEN, GEVA, NPRO, VPHM
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 01 2009 | BCRX | BIOCRYST PHARMACEU ... | 14159 capital (GP), LLC | 10% Owner | Sell | S | 3.89 | 1,314 | 5,105 | 120,828 | 122.1 K to 120.8 K (-1.08 %) |
Jun 01 2009 | BCRX | BIOCRYST PHARMACEU ... | 14159 capital (GP), LLC | 10% Owner | Sell | S | 3.86 | 3,392 | 13,107 | 122,142 | 125.5 K to 122.1 K (-2.70 %) |
Jun 01 2009 | BCRX | BIOCRYST PHARMACEU ... | 14159 capital (GP), LLC | 10% Owner | Sell | S | 4.12 | 3,249 | 13,395 | 125,534 | 128.8 K to 125.5 K (-2.52 %) |
Jun 01 2009 | BCRX | BIOCRYST PHARMACEU ... | 14159 capital (GP), LLC | 10% Owner | Sell | S | 4.30 | 631 | 2,714 | 128,783 | 129.4 K to 128.8 K (-0.49 %) |
Jun 01 2009 | BCRX | BIOCRYST PHARMACEU ... | 14159 capital (GP), LLC | 10% Owner | Sell | S | 4.50 | 4,677 | 21,066 | 129,414 | 134.1 K to 129.4 K (-3.49 %) |
Jun 01 2009 | BCRX | BIOCRYST PHARMACEU ... | 14159 capital (GP), LLC | 10% Owner | Sell | S | 4.45 | 2,597 | 11,566 | 134,091 | 136.7 K to 134.1 K (-1.90 %) |
Nov 24 2008 | BCRX | BIOCRYST PHARMACEU ... | 14159 capital (GP), LLC | 10% Owner | Buy | P | 0.98 | 201 | 197 | 136,688 | 136.5 K to 136.7 K (+0.15 %) |
Nov 24 2008 | BCRX | BIOCRYST PHARMACEU ... | 14159 capital (GP), LLC | 10% Owner | Buy | P | 0.91 | 848 | 775 | 136,487 | 135.6 K to 136.5 K (+0.63 %) |
Nov 24 2008 | BCRX | BIOCRYST PHARMACEU ... | 14159 capital (GP), LLC | 10% Owner | Buy | P | 1.00 | 8,278 | 8,278 | 135,639 | 127.4 K to 135.6 K (+6.50 %) |
Page: 1